List of Verrica Pharmaceuticals patents | 6 results

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11147790 Treatment of cutaneous disorders	Patent 11147790 was granted and assigned to Verrica Pharmaceuticals on October, 2021 by the United States Patent and Trademark Office.	Verrica Pharmaceuticals	Verrica Pharmaceuticals	United States Patent and Trademark Office	11147790	October 19, 2021
‌ US Patent 11052064 Compositions, methods and systems for the treatment of cutaneous disorders	Patent 11052064 was granted and assigned to Verrica Pharmaceuticals on July, 2021 by the United States Patent and Trademark Office.	Verrica Pharmaceuticals	Verrica Pharmaceuticals	United States Patent and Trademark Office	11052064	July 6, 2021
‌ US Patent 11168091 Quantification and preparation of pharmaceutical grade cantharidin	Patent 11168091 was granted and assigned to Verrica Pharmaceuticals on November, 2021 by the United States Patent and Trademark Office.	Verrica Pharmaceuticals	Verrica Pharmaceuticals	United States Patent and Trademark Office	11168091	November 9, 2021
‌ US Patent D983407 Ampule crush tool	Patent D983407 was granted and assigned to Verrica Pharmaceuticals on April, 2023 by the United States Patent and Trademark Office.	Verrica Pharmaceuticals	Verrica Pharmaceuticals	United States Patent and Trademark Office	D983407	April 11, 2023
‌ US Patent D900312 Applicator	Patent D900312 was granted and assigned to Verrica Pharmaceuticals on October, 2020 by the United States Patent and Trademark Office.	Verrica Pharmaceuticals	Verrica Pharmaceuticals	United States Patent and Trademark Office	D900312	October 27, 2020
‌ US Patent 10745413 Commercially viable synthesis of cantharidin and bioactive cantharidin derivatives	Patent 10745413 was granted and assigned to Verrica Pharmaceuticals on August, 2020 by the United States Patent and Trademark Office.		Verrica Pharmaceuticals	United States Patent and Trademark Office	10745413	August 18, 2020